The Pulmonary Vascular Research Institute

Generated important new data?
Late-breaking abstract submissions are now open 📢

PVRI 2027 Bangkok is now accepting late-breaking abstracts showcasing highly impactful findings. We are particularly interested in:

🔬 major clinical trials
📊 landmark registry analyses
🧬 transformative translational discoveries
💡 emerging technologies with immediate clinical relevance

Late-breaking submissions provide an opportunity to share the very latest advances with the global PH community and help shape discussions at PVRI 2027 Bangkok.

📅 Deadline: 30 November 2026, 09:00 GMT
➡️ Submit your abstract: pvrinstitute.org/pvri2027/abstr…

We're proud to support #PHDayUK 2026 💜

Raising awareness is an important step towards earlier diagnosis, better understanding and improved outcomes for people living with PH.

That's why we're backing this year's #WeNeedToTalkAboutPH campaign. Every conversation helps more people recognise the signs and symptoms of PH and understand the impact it can have on daily life.

Join us in supporting this year's campaign: phday.phauk.org/get-involved#g…

✅ Is taking part in a clinical trial right for you?

There is no single right answer. Every person, situation, and clinical trial is different.

In this video from our 'Understanding clinical trials' PH patient collection, Huan Huang from PHA China explores some of the factors patients may wish to consider when making decisions about research participation.

🎥 Watch the full series: pvrinstitute.org/PH-patient-res…

One week to go! ⏳️

Blood Biomarkers in PAH – New Insights
📅 12 November 2026
🕓️ 16:00 - 17:00 GMT

You'll hear talks on:

▪️Validation of biomarkers for clinical use: methological challenges and the path forward - Anna Hemnes, Vanderbilt University
▪️Use of the plasma proteosome for risk stratifying patients with PAH
Christopher J. Rhodes, National Heart and Lung Institute, Imperial College
▪️NOTCH3-ECD as a Biomarker for PAH - Patricia A. Thistlethwaite, University of California
▪️Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in PAH - Mona Alotaibi, University of California San Diego
▪️Blood endostatin, a Collagen18a1 fragment, as markers of vascular dysfunction in PAH - Grazyna Kwapiszewska, University of Graz

➡️ Register now: pvrinstitute.org/learning-hub/e…

You may know the right clinician 💬

Global PH Consult gives clinicians the opportunity to bring anonymised complex PH cases to a tailored panel of PH specialists for discussion and shared learning.

Help us spread the word by sharing Global PH Consult with:

▪️colleagues managing complex PH cases
▪️regional PH centres
▪️clinical networks and professional societies
▪️clinicians working in low- and middle-income countries

A single recommendation could connect a clinician with valuable PH discussion, specialist perspectives, and a global learning community.

➡️ Find out more: pvrinstitute.org/learning-resea…